226 related articles for article (PubMed ID: 15023469)
1. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics.
Nakamura K; Murray RJ; Joseph JI; Peppas NA; Morishita M; Lowman AM
J Control Release; 2004 Mar; 95(3):589-99. PubMed ID: 15023469
[TBL] [Abstract][Full Text] [Related]
2. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
Kumar A; Lahiri SS; Singh H
Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
[TBL] [Abstract][Full Text] [Related]
3. Antiproteolytic action of orally delivered insulin using pH-responsive hydrogels in a rat burn model.
Madihally SV; Pantelogianis A; Toner M
J Surg Res; 2006 Sep; 135(1):187-94. PubMed ID: 16616764
[TBL] [Abstract][Full Text] [Related]
4. Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy.
Tuesca A; Nakamura K; Morishita M; Joseph J; Peppas N; Lowman A
J Pharm Sci; 2008 Jul; 97(7):2607-18. PubMed ID: 17876768
[TBL] [Abstract][Full Text] [Related]
5. Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.
Fukuoka Y; Khafagy ES; Goto T; Kamei N; Takayama K; Peppas NA; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(5):811-814. PubMed ID: 29709919
[TBL] [Abstract][Full Text] [Related]
6. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
Morishita M; Goto T; Peppas NA; Joseph JI; Torjman MC; Munsick C; Nakamura K; Yamagata T; Takayama K; Lowman AM
J Control Release; 2004 May; 97(1):115-24. PubMed ID: 15147809
[TBL] [Abstract][Full Text] [Related]
7. Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration.
Besheer A; Wood KM; Peppas NA; Mäder K
J Control Release; 2006 Mar; 111(1-2):73-80. PubMed ID: 16460830
[TBL] [Abstract][Full Text] [Related]
8. Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids.
Perakslis E; Tuesca A; Lowman A
J Biomater Sci Polym Ed; 2007; 18(12):1475-90. PubMed ID: 17988515
[TBL] [Abstract][Full Text] [Related]
9. The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: hydrogel dissolution and insulin release under neutral pH condition.
Nam K; Watanabe J; Ishihara K
Eur J Pharm Sci; 2004 Nov; 23(3):261-70. PubMed ID: 15489127
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
[TBL] [Abstract][Full Text] [Related]
12. The use of colloidal microgels as a (trans)dermal drug delivery system.
Lopez VC; Hadgraft J; Snowden MJ
Int J Pharm; 2005 Mar; 292(1-2):137-47. PubMed ID: 15725560
[TBL] [Abstract][Full Text] [Related]
13. Release behaviour and biocompatibility of drug-loaded pH sensitive particles.
Sipahigil O; Gürsoy A; Cakalağaoğlu F; Okar I
Int J Pharm; 2006 Mar; 311(1-2):130-8. PubMed ID: 16427223
[TBL] [Abstract][Full Text] [Related]
14. Dependence of copolymer composition, swelling history, and drug concentration on the loading of diltiazem hydrochloride (DIL.HCl) into poly[(N-isopropylacrylamide)-co-(methacrylic acid)] hydrogels and its release behaviour from hydrogel slabs.
Sousa RG; Prior-Cabanillas A; Quijada-Garrido I; Barrales-Rienda JM
J Control Release; 2005 Feb; 102(3):595-606. PubMed ID: 15681082
[TBL] [Abstract][Full Text] [Related]
15. Release characteristics of novel pH-sensitive p(HEMA-DMAEMA) hydrogels containing 3-(trimethoxy-silyl) propyl methacrylate.
Brahim S; Narinesingh D; Guiseppi-Elie A
Biomacromolecules; 2003; 4(5):1224-31. PubMed ID: 12959587
[TBL] [Abstract][Full Text] [Related]
16. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates.
Kavimandan NJ; Losi E; Peppas NA
Biomaterials; 2006 Jul; 27(20):3846-54. PubMed ID: 16529810
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of poly(methoxyl ethylene glycol-caprolactone-co-methacrylic acid-co-poly(ethylene glycol) methyl ether methacrylate) pH-sensitive hydrogel for delivery of dexamethasone.
Wang K; Xu X; Wang Y; Yan X; Guo G; Huang M; Luo F; Zhao X; Wei Y; Qian Z
Int J Pharm; 2010 Apr; 389(1-2):130-8. PubMed ID: 20096758
[TBL] [Abstract][Full Text] [Related]
18. Devices based on intelligent biopolymers for oral protein delivery.
Peppas NA
Int J Pharm; 2004 Jun; 277(1-2):11-7. PubMed ID: 15158964
[TBL] [Abstract][Full Text] [Related]
19. Swelling behavior and release properties of pH-sensitive hydrogels based on methacrylic derivatives.
Bartil T; Bounekhel M; Cedric C; Jeerome R
Acta Pharm; 2007 Sep; 57(3):301-14. PubMed ID: 17878110
[TBL] [Abstract][Full Text] [Related]
20. Poly(MAA-co-AN) hydrogels with improved mechanical properties for theophylline controlled delivery.
Luo Y; Zhang K; Wei Q; Liu Z; Chen Y
Acta Biomater; 2009 Jan; 5(1):316-27. PubMed ID: 18723415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
